Stocks and Investing Stocks and Investing
Fri, October 7, 2016

FXC, CAB, AVEO, NEPT, TSLA, HIMX Are Seasonally Ripe To Go Down In the Next Five Weeks


Published on 2016-10-07 01:46:17 - WOPRAI
  Print publication without navigation


October 7, 2016 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net is monitoring the Seasonality of CurrencyShares Canadian Dollar Trust (NYSE:FXC), Cabela's Incorporated (NYSE:CAB), AVEO Pharmaceuticals Inc. (NASDAQ:AVEO), Neptun SA (NASDAQ:NEPT), Tesla Motors Inc. (NASDAQ:TSLA), Himax Technologies Inc. (NASDAQ:HIMX) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. buyins.net is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

The following stocks are expected to go Down:

  Symbol  Company                          Expected Return  Odds                 By The Following Date
  FXC     CurrencyShares Canadian Dollar Trust  -1.44%           100.00% (10 of 10)   Monday, November 21st 2016
  CAB     Cabela's Incorporated            -10.58%          75.00% (9 of 12)     Monday, October 31st 2016
  AVEO    AVEO Pharmaceuticals Inc.        -9.03%           100.00% (6 of 6)     Friday, November 18th 2016
  NEPT    Neptun SA                        -7.13%           100.00% (9 of 9)     Thursday, October 20th 2016
  TSLA    Tesla Motors Inc.                -1.60%           100.00% (6 of 6)     Tuesday, October 18th 2016
  HIMX    Himax Technologies Inc.          -10.00%          90.00% (9 of 10)     Monday, October 24th 2016
CurrencyShares Canadian Dollar Trust (NYSE:FXC) - Currencyshrs Can Dollar.

Cabela's Incorporated (NYSE:CAB) - Cabela s Incorporated operates as a specialty retailer and direct marketer of hunting, fishing, camping, and related outdoor merchandise. The company operates through Retail, Direct, and Financial Services segments. The Retail segment sells products and services through its retail stores The Direct segment sells products through its e-commerce websites, including Cabelas.com and Cabelas.ca; and direct mail catalogs. The Financial Services segment issues Cabela s CLUB Visa credit card, a rewards based credit card program; and certificates of deposit, as well as underwrites credit statistics. This segment offers its Cabela s CLUB Visa credit card through various channels, including retail stores, Website, inbound telemarketing, and catalogs. The company s product assortment includes hunting equipment, such as firearms, ammunition, optics, archery products, and related accessories and supplies; and field wear apparel and footwear, sportswear apparel and footwear, casual apparel and footwear, and workwear products. Its product assortment also comprises equipment and accessories for various outdoor activities, including fishing and tackle products; boats, electronics, and marine accessories and equipment; camping gear and equipment; food preparation and outdoor cooking products; all-terrain vehicles and accessories; and gifts and home furnishings. The company operates 77 retail stores, including 68 stores in the United States; and 9 stores in Canada. Cabela s Incorporated was founded in 1961 and is headquartered in Sidney, Nebraska..

AVEO Pharmaceuticals Inc. (NASDAQ:AVEO) - AVEO Pharmaceuticals, Inc., a biopharmaceutical company, develops targeted therapies for patients with cancer and related diseases. The company s pipeline of product candidates include Tivozanib, an tyrosine kinase inhibitor for various vascular endothelial growth factors for renal cell carcinoma and other cancers; Ficlatuzumab, an anti-hepatocyte growth factor inhibitory antibody, which has completed Phase II trial; and AV-203, an anti-ErbB3 monoclonal antibody that has completed a Phase I dose escalation study. Its development programs also comprise AV-380 Program, a humanized IgG1 inhibitory monoclonal antibody for the treatment or prevention of cachexia, which is a multi-factorial syndrome of involuntary weight loss associated with various cancers and diseases outside of cancer, including chronic kidney disease, congestive heart failure, and chronic obstructive pulmonary disease. It has strategic partnerships with Ophthotech Corporation; Biodesix, Inc.; St. Vincent s Hospital Sydney Limited; Biogen Idec Inc.; and Kyowa Hakko Kirin. The company was formerly known as GenPath Pharmaceuticals, Inc. and changed its name to AVEO Pharmaceuticals, Inc. in March 2005. AVEO Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Cambridge, Massachusetts..

Neptun SA (NASDAQ:NEPT) - Neptune Technologies & Bioressources Inc., a nutrition company, develops, manufactures, and commercializes marine-derived omega-3 polyunsaturated fatty acids from Antarctic krill. The company also provides custom-made nutraceutical finished products from marine oils, and various other functional ingredients. Its products include Neptune Krill Oil (NKO), which provides omega-3 with superior bioavailability and antioxidant content; NKO Beat improves heart health; NKO Flex provides joint and bone health benefits; and NKO Focus provides brain and vision health. In addition, the company is pursuing opportunities in the prescription drug markets, through its subsidiary, Acasti Pharma Inc., that focuses on the research and development of compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases. It markets and sells its products in Canada, the United States, France, Belgium, Australia, the United Kingdom, and other countries. Neptune Technologies & Bioressources Inc. was founded in 1925 and is headquartered in Laval, Canada..

Tesla Motors Inc. (NASDAQ:TSLA) - Tesla Motors, Inc. designs, develops, manufactures, and sells electric vehicles and stationary energy storage products in the United States, China, Norway, and internationally. It primarily offers sedans and sport utility vehicles. The company also offers electric vehicle powertrain components and systems to other manufacturers. Tesla Motors, Inc. sells its products through a network of Tesla stores and galleries, as well as through Internet. The company was founded in 2003 and is headquartered in Palo Alto, California..

Himax Technologies Inc. (NASDAQ:HIMX) - Himax Technologies, Inc., a fabless semiconductor company, provides display imaging processing technologies to consumer electronics worldwide. The company operates through Driver IC and Non-Driver Products segments. It offers display driver integrated circuits (ICs) and timing controllers used in televisions (TVs), laptops, monitors, mobile phones, tablets, digital cameras, car navigation, and other consumer electronics devices. The company also designs and provides controllers for touch sensor displays, liquid crystal on silicon micro-displays used in palm-size projectors and head-mounted displays, light-emitting diode driver ICs, power management ICs, scaler products for monitors and projectors, tailor-made video processing IC solutions, and silicon IPs. In addition, it offers digital camera solutions, including complementary metal oxide semiconductor image sensors and wafer level optics, which are used in various applications, such as mobile phone, tablet, laptop, TV, PC camera, automobile, security, and medical devices. The company markets its products to panel manufacturers, agents or distributors, module manufacturers, and assembly houses; and camera module manufacturers, optical engine manufacturers, and television system manufacturers. Himax Technologies, Inc. was founded in 2001 and headquartered in Tainan City, Taiwan..

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net


Contributing Sources